Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1

Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial

Published:2020-01 Issue:1 Volume:21 Page:121-133
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Geoerger Birgit,Kang Hyoung Jin,Yalon-Oren Michal,Marshall Lynley V,Vezina Catherine,Pappo Alberto,Laetsch Theodore W,Petrilli Antonio S,Ebinger Martin,Toporski Jacek,Glade-Bender Julia,Nicholls Wayne,Fox Elizabeth,DuBois Steven G,Macy Margaret E,Cohn Susan L,Pathiraja Kumudu,Diede Scott J,Ebbinghaus Scot,Pinto Navin

Publisher

Elsevier BV

Subject

Oncology

Reference34 articles.

1. Harnessing the immunotherapy revolution for the treatment of childhood cancers;Majzner;Cancer Cell,2017

2. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

3. Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues;Majzner;Cancer,2017

4. Pediatric cancers are infiltrated predominantly by macrophages and contain a paucity of dendritic cells: a major nosologic difference with adult tumors;Vakkila;Clin Cancer Res,2006

5. Phase I clinical trial of ipilimumab in pediatric patients with advanced solid tumors;Merchant;Clin Cancer Res,2016

Cited by 224 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study);European Journal of Cancer;2024-11

2. Immune checkpoint markers and tumour mutation burden in Wilms tumour: a study of 59 cases;Pathology;2024-10

3. Cancer immunotherapy of Wilms tumor: a narrative review;Future Oncology;2024-09-05

4. Pediatric thyroid side effects of immune checkpoint inhibitors;Trends in Endocrinology & Metabolism;2024-09

5. Pediatric Adrenocortical Carcinoma: The Nuts and Bolts of Diagnosis and Treatment and Avenues for Future Discovery;Cancer Management and Research;2024-09